Isabelle Peene, MD, PhD, recaps efgartigimod data showing maintained CRESS response and low disease activity through 48 weeks in the Sjögren's disease RHO+ OLE.
Isabelle Peene, MD, PhD
Advertisement
Isabelle Peene, MD, PhD, is affiliated with Ghent University Hospitaland the VIB Center for Inflammation Research at Ghent Unversity in Belgium.
Articles by Isabelle Peene, MD, PhD
Advertisement